Michael Celano - 17 May 2023 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role: Chief Financial Officer
Signature: /s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol: LRMR
Transactions as of: 17 May 2023
Net transactions value: +$18,632
Form type: 4
Filing time: 18 May 2023, 14:13:33 UTC
Previous filing: 02 Feb 2023
Next filing: 19 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LRMR	Common Stock	Purchase	$18,632	+5,000	+4.6%	$3.73	112,746	17 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.